Remarkable Health Names Drew Schulz as Director of Corporate Development
Habazar Internet Marketing and Social Media Campaign Management
Remarkable Health Names Drew Schulz as Director of Corporate Development
SCOTTSDALE, Ariz. (PRWEB) April 18, 2018
Remarkable Health is proud to announce that Drew Schulz has joined the company as Director of Corporate Development and will lead strategic projects, partnerships and M&A at Remarkable Health.
Peter Flick, President & Chief Executive Officer, said, “Drew has deep domain experience in uncovering latent value, especially around technology that touches people, making him a strong addition to the company.”
Along with Peter, Drew will lead strategic initiatives to drive outsize value growth at Remarkable Health. Drew stated, “I’m honored and excited to be part of this Remarkable team who have consistently created extraordinary outcomes for customers.”
Prior to Remarkable Health, Drew was Director of Corporate Development at Madison Reed where he led the $25 million Series C fundraise and other strategic initiatives. Drew also spent time at GE Ventures focused on early stage and growth funds’ strategy, was part of the Technology Investment Banking Group at Morgan Stanley, and is an angel investor and advisor to several early stage companies. He started his career as a management consultant at ZS Associates and earned his MBA at The Wharton School at the University of Pennsylvania.
For additional information, visit https://www.remarkablehealth.com/.
About Remarkable Health
Remarkable Health is a 25-year pioneer offering practice management software to the Behavioral Health and Human Service community. Our provider success platform enables health care providers to improve more lives by spending less time in front of a screen and more time helping their clients. Our flagship product, CT|One is a complete hosted Electronic Health Record (EHR) – Clinical, Billing, Scheduling, Medication Management / e-Prescribing, Reporting, etc. – for inpatient, outpatient and residential settings.